The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
The metabolism and bioavailability of morphine in patients with severe liver cirrhosis.
Open accessAbstract
1. The oral and intravenous kinetics of morphine were investigated in seven cirrhotic patients with a history of encephalopathy. The plasma concentrations of morphine and its metabolites morphine‐3 (M3G) and morphine‐6 (M6G) were measured by h.p.l.c. 2. The mean terminal elimination half‐life of morphine was 4.2 h (95% CI 3.6‐4.8) the mean volume of distribution was 4.1 l kg‐1 (95% CI 2.9‐5.4) and the mean plasma clearance was 11.4 ml min‐1 kg‐1 (95% CI 8.1‐14.7). The mean oral bioavailability was 101% (95% CI 56‐147). 3. The plasma clearance of morphine was significantly lower, its terminal elimination half‐life longer and its oral bioavailability greater in the cirrhotic patients compared with patients with normal liver function. The metabolic ratio M3G/morphine was significantly lower in the cirrhotic patients than in control subjects after oral dosing, but did not differ after intravenous dosing. 4. The average urinary recoveries of morphine plus M3G and M6G were 49.9% after i.v. and 57.7% after oral administration. There were no statistically significant differences in the urinary recovery between the two routes of administration or between the cirrhotic patients and controls. 5. Specific changes in the EEG pattern could not be detected after intravenous dosage. 6. The metabolism of morphine is impaired significantly in patients with severe cirrhosis. Clinically important findings were a high oral bioavailability and a long elimination half‐life. These findings call for cautious dosing of oral and intravenous morphine in patients with severe end stage liver disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Transection of the oesophagus for bleeding oesophageal varices
Pugh, R. N. H., Murray-Lyon, I. M., Dawson, J. L., Pietroni, M. C., & Williams, R. (1973) · Journal of British Surgery · doi:10.1002/bjs.1800600817 · Cited by 7,941
Cited by
Pharmacokinetics and dosage adjustment in patients with renal dysfunction
Verbeeck, R. K., & Musuamba, F. T. (2009) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-009-0678-8 · Cited by 717
Smith, H. S. (2009) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(11)60750-7 · Cited by 696
Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction
Verbeeck, R. K. (2008) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-008-0553-z · Cited by 652
Strategies to Manage the Adverse Effects of Oral Morphine: An Evidence-Based Report
Cherny, N., Ripamonti, C., Pereira, J., Davis, C., Fallon, M., McQuay, H., Mercadante, S., Pasternak, G., Ventafridda, V., & for the Expert Working Group of the European Association of Palliative Care Network (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.9.2542 · Cited by 626
McQuay, H. (1999) · The Lancet · doi:10.1016/s0140-6736(99)03528-x · Cited by 414
Metadata
- Authors
- Hasselstrom, J., Eriksson, S., Persson, A., Rane, A., Svensson, J., & Sawe, J.
- Venue
- British Journal of Clinical Pharmacology
- Publisher
- Wiley
- Published
- 1990-03
- Volume
- 29
- Issue
- 3
- Pages
- 289-297
- ISSN
- 0306-5251 (ISSN-L)
- 1365-2125
- OpenAlex
- W1985750268
- Cited by
- 205
- References
- 1
- FWCI
- 5.04
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The metabolism and bioavailability of morphine in patients with severe liver cirrhosis. https://app.cochat.ai/papers/10.1111/j.1365-2125.1990.tb03638.x
- The paper
- Hasselstrom, J., Eriksson, S., Persson, A., Rane, A., Svensson, J., & Sawe, J. (1990). The metabolism and bioavailability of morphine in patients with severe liver cirrhosis. British Journal of Clinical Pharmacology. https://doi.org/10.1111/j.1365-2125.1990.tb03638.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.